Lentiviral Vectors and Protocols for Creation of Stable hESC Lines for Fluorescent Tracking and Drug Resistance Selection of Cardiomyocytes
Open Access
- 8 April 2009
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 4 (4), e5046
- https://doi.org/10.1371/journal.pone.0005046
Abstract
Developmental, physiological and tissue engineering studies critical to the development of successful myocardial regeneration therapies require new ways to effectively visualize and isolate large numbers of fluorescently labeled, functional cardiomyocytes. Here we describe methods for the clonal expansion of engineered hESCs and make available a suite of lentiviral vectors for that combine Blasticidin, Neomycin and Puromycin resistance based drug selection of pure populations of stem cells and cardiomyocytes with ubiquitous or lineage-specific promoters that direct expression of fluorescent proteins to visualize and track cardiomyocytes and their progenitors. The phospho-glycerate kinase (PGK) promoter was used to ubiquitously direct expression of histone-2B fused eGFP and mCherry proteins to the nucleus to monitor DNA content and enable tracking of cell migration and lineage. Vectors with T/Brachyury and α-myosin heavy chain (αMHC) promoters targeted fluorescent or drug-resistance proteins to early mesoderm and cardiomyocytes. The drug selection protocol yielded 96% pure cardiomyocytes that could be cultured for over 4 months. Puromycin-selected cardiomyocytes exhibited a gene expression profile similar to that of adult human cardiomyocytes and generated force and action potentials consistent with normal fetal cardiomyocytes, documenting these parameters in hESC-derived cardiomyocytes and validating that the selected cells retained normal differentiation and function. The protocols, vectors and gene expression data comprise tools to enhance cardiomyocyte production for large-scale applications.Keywords
This publication has 39 references indexed in Scilit:
- Substrate Stiffness Affects the Functional Maturation of Neonatal Rat Ventricular MyocytesBiophysical Journal, 2008
- Human Embryonic Stem Cell–Derived Cardiomyocytes and Cardiac Repair in RodentsCirculation Research, 2008
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Alternative Splicing Events Identified in Human Embryonic Stem Cells and Neural ProgenitorsPLoS Computational Biology, 2007
- Functional Sarcoplasmic Reticulum for Calcium Handling of Human Embryonic Stem Cell-Derived Cardiomyocytes: Insights for Driven MaturationThe International Journal of Cell Cloning, 2007
- A ROCK inhibitor permits survival of dissociated human embryonic stem cellsNature Biotechnology, 2007
- Functional proteometrics for cell migrationCytometry Part A, 2006
- Functional Properties of Human Embryonic Stem Cell–Derived Cardiomyocytes: Intracellular Ca2+ Handling and the Role of Sarcoplasmic Reticulum in the ContractionThe International Journal of Cell Cloning, 2005
- Endothelial Cells Promote Cardiac Myocyte Survival and Spatial ReorganizationCirculation, 2004
- Active force in rabbit ventricular myocytesJournal of Biomechanics, 1995